Search Results
Neoadjuvant T-DM1 in HER2+ Early Breast Cancer
Dr. Jhaveri Discusses the Utility of T-DM1 in the Neoadjuvant Setting
HER2+ Early-Stage Breast Cancer: Peri-Operative Therapy
Treating Early HER2+ Breast Cancer: KATHERINE
Optimizing Therapy in HER2+ Disease with Dr. Reshma Mahtani
Dr. Hamilton on ONT-380/T-DM1 in HER2+ Breast Cancer
HER2+ Early-Stage Breast Cancer: Neoadjuvant Strategies
5-year correlative analysis of ATEMPT: adjuvant T-DM1 vs paclitaxel+trastuzumab for stage I HER2+ BC
Neoadjuvant Approaches for Early-Stage HER2+ Breast Cancers
Impact of biomarkers on pCR and survival after T-DM1 with or without ET vs trastuzumab and ET in...
KATHERINE Trial: T-DM1 cuts HER2-positve invasive breast cancer recurrence
Upfront T-DM1 in HER2-Positive Breast Cancer